Albany, NY -- (SBWIRE) -- 04/05/2018 -- Human Embryonic Stem Cells Market: Overview

Human embryonic stem cells (hESCs) are derived from blastocyst and are capable of differentiating into number of cell types that make up the human body. hESCs can replicate indefinitely and produce non-regenerative tissues such as neural and myocardial cells. These abilities of human embryonic stems cells allow them to be used as a tool in regenerative medicine and research. Because of their capacity for self-renewal, they can be used in treating a number of blood and genetic disorders related to the immune system, cancers, and disorders. Human embryonic stem cells are also used in investigational studies of early human development, genetic diseases and toxicology testing.

Download PDF Brochure of Report:https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1593


The global human embryonic stem cells market is categorized on the basis of following applications:


- Toxicology testing

- Tissue engineering

- Regenerative medicines

- Stem cell biology research


Currently, North America dominates the global human embryonic stem cells market and is followed by Europe due to high prevalence of cardiac and malignant diseases. Developing nations of Asia, Middle East and Latin America are also expected to show rapid growth in this market due to increasing medical tourism and the flourishing contract research outsourcing market in these regions.

The major factors driving the demand for human embryonic stem cells include extensive therapeutic research activities in this field, rapid growth in medical tourism, emerging stem cell banking services. Additionally, increase in incidences of cardiac and neurological disorders around the world owing to the stressful lifestyle and receipt of funds from various organizations will also propel the growth of this market.

Request to View TOC of Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1593


Some of the key players contributing to the human embryonic stem cells market include Australian Stem Cell Centre, BD Biosciences, Cellartis AB, Millipore Corporation, Geron Corporation, Invitrogen Corporation, Viacyte, Inc., R&D Systems, Inc., SA Biosciences Corporation, Tataa Biocenter, Thermo Scientific and Vitrolife AB.

Request to View Discount –https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1593